학술논문
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
Document Type
Article
Author
Li, Ziming; Dang, Xiaomin; Huang, Dingzhi; Jin, Shi; Li, Weiwei; Shi, Jianhua; Wang, Xicheng; Zhang, Yiping; Song, Zhengbo; Zhang, Junping; Zhuang, Wu; Liu, Xuewen; Jiang, Liyan; Meng, Xiangjiao; Zhao, Mingfang; Zhou, Jianying; Zhang, Liangming; Wang, Pingli; Luo, Hui; Yang, Junquan; Cang, Shundong; Wang, Xiang; Wang, Jing; Cui, Jiuwei; Yu, Yan; Zhang, Zhihong; Lu, Junguo; Yang, Weihua; Li, Gaofeng; Feng, Jifeng; Lv, Dongqing; Wu, Lin; Fang, Yong; Wang, Yan; Zhao, Yanqiu; Cao, Baoshan; Zhu, Wei; Zhuang, Zhixiang; Li, Qingshan; Wang, Mingxi; Zhou, Huan; Dong, Xiaorong; Hu, Sheng; Fang, Jian; Xu, Chun-Wei; Zhang, Yihong; Wang, Wenjia; Xiang, Ziyong; Shi, Zhe; Wang, Yaolin; Zhang, Ling; Lu, Shun
Source
In The Lancet Respiratory Medicine August 2024 12(8):589-598
Subject
Language
ISSN
2213-2600